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Background: Pathophysiology of essential hypertension remains obscure. Correlation among
ventricular ejection force, sympathetic activity, and hypertension is less clearly narrated in
hypertensive subjects.
Aims and objectives: To assess correlation among ventricular ejection force, sympathetic
activity, and hypertension in hypertensive subjects, and to be compared with normotensive
subjects.
Methods: This is a case–control study to assess left ventricular ejection force (LVEF) and
sympathetic skin response, in normotensive (group 1; control), and hypertensive subjects
(group 2; cases). 100 cases were selected. Subjects having stages 1 and 2 hypertension were
categorized in groups 2A and 2B, respectively. LVEF was calculated by using echocardiogra-
phy observing aortic acceleration time (AT) and peak systolic velocity. Comparison among
groups was done by using one-way ANOVA.
Results: Both groups were comparable. In group 2, 60 cases had stage 1 hypertension and 40
had stage 2 hypertension. Signiﬁcantly short AT and signiﬁcantly high LVEF were found in
hypertension (groups 2A and 2B) ( p < 0.0001). Sympathetic activity was high in group 2A
(p < 0.0001). Stroke volume (SV) was high in group 2B (p < 0.0001).
Conclusion: Stage 1 hypertension is a stage of increased sympathetic activity, leading to
increased LVEF and hypertension (resetting of baroreceptors); stage 2 hypertension is a stage
of normal sympathetic activity, increased LVEF, increased SV, and hypertension (possibly a
stage of shift of renal equilibrium curve/renal output curve and blood pressure to a newer
level).
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1. Introduction
Essential hypertension1 affecting 95% of hypertensive patients
has no identiﬁable cause.2–4 According to Joint National
Committee report (JNC 7), blood pressure ≥140/90 mmHg is
hypertension.5 Various risk factors associated with hyperten-
sion are obesity,6 salt sensitivity,7 genetics,8 obstructive sleep
apnea,9 insulin resistance,10 sympathetic over activity,11,12 etc.
Despite awareness of multiple risk factors, pathophysiology of
hypertension remains ambiguous. In normotensive subjects,
sympathetic stimulation results in increase in heart rate,
cardiac contractility (ejection force), and peripheral resis-
tance,13 but in hypertensive subjects, correlation among
sympathetic activity, cardiac contractility and hypertension
is less clearly illustrated. Therefore, the main aim of the study
was to assess any correlation among these factors in
hypertensive subjects and to be compared with normotensive
subjects, in a case–control manner.
2. Methods
This is a double-blind comparative observational exploratory
Fig. 1 – Aortic flow.
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(LVEF), sympathetic nervous system activity, and stroke
volume (SV) in normotensive (group 1; control group) and
hypertensive subjects (group 2; cases). All the cases were
newly diagnosed, i.e. no previous history of treatment of
hypertension. Arbitrarily, 100 controls and an equal number
of hypertensive cases were opted for the study. Informed
written consent and approval of institutional ethical com-
mittee was taken. In group 2, subjects having stage 1
hypertension were categorized in group 2A while stage 2
hypertension was categorized in group 2B. Cases and controls
were randomly selected from medical Out Patient Depart-
ment (OPD) of Mittal Hospital and Research Centre, Pushkar
Road, Ajmer, Rajasthan, India. Recruitment was done from
January 2015 to March 2015. In both the groups, the age group
was 35–40 years; all participants were male. Cases having
coronary artery disease, thyroid disease, diabetes, left
ventricular hypertrophy, aortic valvular disease, and history
suggestive of neuropathy, which could affect echocardio-
graphic ﬁndings/sympathetic skin response (SSR), were
excluded. Assessment was done only once, i.e. at the time
of ﬁrst examination (0 month). The following parameters
were examined
(1) Complete examination including body mass index (BMI),
resting pulse rate, and respiratory rate
(2) Left ventricular ejection force (LVEF)
(3) Sympathetic skin response (SSR)
(4) Stroke volume (SV)
Left ventricular ejection force – This was assessed with
the help of echocardiography by applying Newton's second
law of motion.14 This law states that force is equal to the
product of mass and acceleration. Ventricular ejection force
does not require estimation of ventricular volume and is
independent of ventricular conﬁguration. Five-chambertransthoracic view was used with the help of image-directed
continuous wave Doppler echocardiography15,16 (GE Vivid S6
with probe frequency 1.7 MHz). Aortic peak systolic velocity
(PSV), aortic acceleration time (AT)/time to peak velocity
interval (TTP), time–velocity integral during the acceleration
phase of the cardiac cycle (TVIac), and heart rate were
measured. TVIac represents the area under the Doppler
envelope from the beginning of systole to PSV (Fig. 1). Three
consecutive cardiac cycles were examined and their mean
was used for analysis. The diameter of aortic valve was
measured from frozen real time images during systole by
using leading edge to leading edge method. The mass of
blood accelerated across aortic valve over a time period was
calculated by multiplying the density of blood, which is 1.055,
by the cross-sectional area (CSA) and TVIac. The acceleration
component was calculated by dividing the PSV by TTP. LVEF
was calculated by using a formula (1.055  CSA  TVIac) 
(PSV/TTP).17,18
Sympathetic skin response was done with standard
protocol in supine, relaxed, semi-darkened room with ambient
temperature control at 22–24 8C in the upper limbs. In this
process, standard surface electromyography electrodes (Re-
corder and Medicare system model Aleron 401) were applied
with conducting jelly to the palm and dorsum of the hand,
with a reference electrode on the forearm. Hand grip and cold
pressor were used as provocative methods. Skin potential
changes during and between the tests were analyzed by a
computer. Latency was measured from the onset of stimulus
artifact to the beginning of response. Amplitude was recorded
peak to peak (Fig. 2).19–21
All readings of echocardiography and SSR were recorded by
a senior resident and a senior technician.
Stroke volume was measured in transthoracic 4-chamber
view by subtracting ESV (end systolic volume) from EDV (end
diastolic volume).
Fig. 2 – Sympathetic skin response.
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 6 8 5 – 6 9 2 6872.1. Data analysis
Collected data were entered in Microsoft Excel spreadsheet
and then analyzed by using SPSS 20.0 software. Comparison
between groups 1 and 2 was done by using Mann–Whitney U
test and among group 1, group 2A, and group 2B, it was done by
using one-way ANOVA and post hoc analysis done by Tukey's
test.
3. Results
Both groups 1 and 2 were matched according to age, sex, and
BMI. Pulse rate and respiratory rate were within normal range
in all groups (Table 1). In group 2, 60 cases were having stage 1
hypertension and 40 were having stage 2 hypertension.Table 1 – General examination.
Groups Age (years), mean Sex BMI (kg/m
Group 1 (n = 100) 38 Male 22
Group 2A (n = 60) 39 Male 22
Group 2B (n = 40) 39 Male 22
Table 2 – Cardiac contractility data.
PSV/VMAX (m/s) CSA (104 m2) AT/T
Group 1 (n = 100) 1.176  0.070 3.76  037 
Group 2 (n = 100) 1.452  0.11 3.95  0.26 
Group 2A (n = 60) 1.363  0.038 3.97  0.30 
Group 2B (n = 40) 1.586  0.024 3.90  0.17 
p value
Group 1 vs. group 2
p value
Group 1 vs. group 2A
p value
Group 1 vs. group 2B
AT/TTP, aortic acceleration time/time to peak velocity interval; CSA, cross
systolic velocity; SV, stroke volume; TVIac, time velocity integral during tSigniﬁcantly short AT was found in all stages of HTN
(p < 0.0001, group 1 vs. group 2A and 1 vs. group 2B) (Table 2;
Fig. 3a–c). LVEF was signiﬁcantly high in groups 2A and 2B
( p < 0.0001, group 1 vs. group 2A and group 1 vs. group 2B)
(Table 2, Fig. 4). Signiﬁcantly high sympathetic skin response
was there in group 2A (group 1 vs. group 2A, p < 0.0001)
(Table 3; Fig. 5a–c). Stroke volume was signiﬁcantly high in
group 2B (p < 0.0001, group 1 vs. group 2B) (Table 2).
Doppler images of aortic ﬂow.
Group 1 Slow/curved acceleration/Long AT,
low PSV
Fig. 3a
Group 2A Sharp acceleration/Short AT, high PSV,
pointed peak
Fig. 3b
Group 2B Sharp acceleration/Short AT, high PSV,
broad based
Fig. 3c
Sympathetic skin response images.
Group 1 Long latency, low amplitude, dome Fig. 5a
Group 2A Short latency, high amplitude, spike Fig. 5b
Group 2B Long latency, low amplitude, dome Fig. 5c
4. Discussion
Pathophysiology of essential hypertension remains elusive.
Various risk factors found to be associated with essential
hypertension are obesity, salt sensitivity, genetics, sympa-
thetic overactivity, etc. In normotensive subjects, increase in
sympathetic activity results in increased cardiac contractility
(cardiac ejection force)13; but in hypertension, the correlation
of sympathetic activity and cardiac contractility is not well
established; therefore, the current study was planned to assess
LVEF and sympathetic activity in a observational case–control
manner in 100 cases of essential hypertension and equal2), mean Pulse rate, mean Respiratory rate, mean
.6 80 14
.8 82 14
.4 78 15
TP (103 s) TVIac (10
2 m) SV (103 L) LVEF (103 N)
92  7.8 6.8  0.43 42.54  4.4 0.35128  0.05
50  4.9 8.0  1.8 53.31  6.4 1.01379  0.38
53  2.7 6.7  0.27 43.23  3.7 0.72383  0.06
44  1.6 10.8  1.2 60.48  1.9 1.44871  0.20
<0.0001 <0.0001
<0.0001 <0.0001
<0.0001 <0.0001
-sectional area; LVEF, left ventricular ejection force; PSV/VMAX, peak
he acceleration phase of cardiac cycle.
Fig. 3 – Doppler images of aortic flow: (a) group 1, (b) group
2A, and (c) group 2B.
Fig. 4 – Ventricular ejection force.
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trols were grouped as group 1 and hypertensive cases were
grouped as group 2. In group 2, stage1 and stage 2 hypertensive
cases were categorized as group 2A and group 2B, respectively.
The cases were examined only once at 0 month. The study was
conducted at Mittal Hospital and Research Centre, Pushkar
road, Ajmer, Rajasthan, India.
All groups were matched according to age, sex, and
BMI. Among vital parameters, resting pulse rate and
respiratory rate were within normal range in all groups
(Table 1).
Findings of the study are divided into two subheadings.4.1. Cardiac ﬁndings (Table 2; Fig. 3–c)
In Doppler aortic ﬂow, three types of ﬂow patterns were
present. In normotensive slow curved acceleration, in stage 1,
hypertension sharp acceleration was with pointed peak, and
in stage 2, hypertension sharp acceleration was with a broad
base (Fig. 3a–c).
In statistical ﬁndings, in group 1 vs. 2A, signiﬁcantly short
AT (p < 0.0001), signiﬁcantly high PSV (p < 0.0001), and
signiﬁcantly high ventricular ejection force (p < 0.0001) was
observed in group 2A. There was no signiﬁcant difference in
stroke volume (p > 0.05). Overall ﬁndings suggest that in group
2A (stage 1 hypertension) there was statistically signiﬁcant
high LVEF and insigniﬁcant difference in stroke volume as
compared to group 1 (normotensive).
In group 1 vs. 2B – signiﬁcantly short AT (p < 0.0001),
signiﬁcantly high PSV (p < 0.0001) and signiﬁcantly high
ventricular ejection force (p < 0.0001) was there in group 2B.
There was signiﬁcant difference in stroke volume (p < 0.0001).
Overall ﬁndings suggest that in group 2B (stage 2 hypertension)
there was statistically signiﬁcant high LVEF and signiﬁcant
difference in stroke volume as compared to group 1 (normo-
tensive).
In group 2A vs. 2B – signiﬁcantly short AT (p < 0.0001),
signiﬁcantly high PSV (p < 0.0001), and signiﬁcantly high
ventricular ejection force (p < 0.0001) was there in group 2B.
There was signiﬁcant difference in stroke volume (p < 0.0001).
Overall ﬁndings suggest that in group 2B (stage 2 hypertension)
there was statistically signiﬁcant high LVEF and signiﬁcant
difference in stroke volume as compared to group 2A (stage 1
hypertension).
As a whole in group 1 vs. group 2 statistically signiﬁcant
high LVEF in group 2 as compared to group 1 (Fig. 4).
Description about LVEF in hypertension is not clear in JNC 7
and JNC 8.1,22
4.2. SSR assessment (Table 3; Fig. 5a–c)
In SSR, there was short latency, high amplitude, spike
response in group 2A, as compared to long latency, low
Table 3 – Sympathetic skin response data.
SSR right/left upper limb Group 1 (mean  SD) Group 2A (mean  SD) Group 2B (mean  SD)
Hand grip
Latency (s) 2.77  0.22 1.01  0.14 2.72  0.23
Amplitude (103 V) 1.24  0.17 6.63  0.88 1.26  0.28
Cold pressor test
Latency (s) 2.81  0.23 0.80  0.16 2.86  0.20
Amplitude (103 V) 1.11  0.27 6.63  1.16 1.24  0.32
Interpretation Normal baseline sympathetic activity High baseline sympathetic activity Normal baseline sympathetic activity
p value: Group 1 vs. 2A
Hand grip latency <0.0001
Hand grip amplitude <0.0001
Cold pressor latency <0.0001
Cold pressor amplitude <0.0001
p value: Group 1 vs. 2B
Hand grip latency 0.47
Hand grip amplitude 0.95
Cold pressor latency 0.36
Cold pressor amplitude 0.54
p value: Group 2A vs. 2B
Hand grip latency <0.0001
Hand grip amplitude <0.0001
Cold pressor latency <0.0001
Cold pressor amplitude <0.0001
Fig. 5 – Sympathetic skin response images: (a) group 1, (b) group 2A, and (c) group 2B.
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(Fig. 5a–c).
There was statistically signiﬁcant difference in latency and
amplitude in group 1 vs. group 2A and group 2A vs. group 2B
( p < 0.0001) (Table 3). Thus, overall ﬁndings suggest increased
sympathetic activity in group 2A (stage 1 hypertension). Short
latency and high amplitude suggestive of high sympathetic
activity is also present in previous studies.19–21
This sympathetic activity is basal sympathetic activity/
basal sympathetic tone.13 Normally, sympathetic system is
continuously active and there is basal secretion of epinephrineFig. 6 – Flow chart – development of hypertension and norepinephrine23 at a very low rate. This tone/secretion is
sufﬁcient to maintain blood pressure at normal level even in
the absence of direct sympathetic stimulation. Basal tone is
different from overt/direct sympathetic stimulation, which
results from direct stimulation of sympathetic nervous system
and adrenal medulla leading to increase in pulse rate,
sweating, etc.13 In the current study, overt sympathetic
stimulation is not present, because resting pulse rate is within
normal range in both groups 2A and 2B (Table 1).
In summary, curved aortic acceleration represents normo-
tensive state and normal sympathetic activity; sharpin study population (hypothesis of the study).
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 6 8 5 – 6 9 2 691acceleration and pointed peak exhibits high sympathetic
activity and stage 1 hypertension; sharp acceleration and
broad base denote stage of high-stroke volume and stage 2
hypertension.
The possible mechanism of hypertension in the study
population seems to begin from normal baseline sympathetic
activity (group 1; normotensive), followed by increase in
baseline sympathetic activity, resulting in increased LVEF,
without signiﬁcantly affecting stroke volume; and this in-
creased ejection force leads to stage 1 hypertension (group 2A)
‘‘Beginning of hypertension from normotensive state’’ (Fig. 6).
At this stage of early blood pressure regulation mecha-
nisms, baroreceptors come into play and try to bring the blood
pressure back to normal; but if this situation persists for >48 h,
early mechanism fails and there is resetting of receptors at a
newer level.24 Late mechanism includes renal mechanism, in
which kidneys increase salt and water excretion (pressure
diuresis) proportionately to increase the blood pressure known
as renal urinary output curve but, increase in sympathetic
activity opposes this effect by increase in renin secretion,24 salt
and water retention, shift of renal equilibrium curve/renal
output curve to a newer level, impaired renal ﬂuid excretion,
and increase in stroke volume resetting of arterial pressure to a
newer level24 (stage 2 hypertension) (now even if sympathetic
activity comes back to normal, blood pressure remains set at
this newer level).
5. Conclusion
In all stages of hypertension, LVEF is high, which primarily
starts from increase in basal sympathetic activity.
However, further studies like community-based observa-
tional and cohort study are required to reach to a ﬁnal
conclusion.
Conﬂicts of interest
The authors have none to declare.
Funding
Mittal Hospital, Ajmer.
Author's contribution
Dr Tarun Saxena contributed in the design of study and writing
of the manuscript; Dr Sanjay Patidar also contributed to
analysis of data and writing of the manuscript; Manjari Saxena
contributed to collection of data and writing of the manuscript.
Acknowledgements
Dr S.R. Mittal (DM Senior Cardiologist), Dr Garima Khichi,
Dr Ramakant Goyal (Radiologist), Dr Harsh Tak (InternalMedicine), Rishi Singh (Echo-technician), Prakash and Arvind
(SSR technician).
r e f e r e n c e s
1. Dosh SA. The treatment of adults with essential
hypertension. J Fam Pract. 2002;51:74–80.
2. Steppan J, Barodka V, Berkowitz DE, Nyhan D. Vascular
stiffness and increased pulse pressure in the aging
cardiovascular system. Cardiol Res Pract. 2011;2011:. http://dx.
doi.org/10.4061/2011/263585. Article ID 263585, 8 pp..
3. Carretero OA, Oparil S. Essential hypertension. Part 1:
deﬁnition and etiology. Circulation. 2000;101:329–335.
4. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of
hypertension. Ann Intern Med. 2003;139:761–776.
5. Chobanian AV, Bakris GL, Black HR, et al. The Seventh
Report of the Joint National Committee on Prevention,
Detection Evaluation, and Treatment of High Blood Pressure:
the JNC 7 report. JAMA. 2003;289:2560–2572.
6. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-
associated hypertension: new insights into mechanisms.
Hypertension. 2005;45:9–14.
7. Katori M, Majima M. A Missing Link Between a High Salt Intake
and Blood Pressure Increase. Kitasato, Sagamihara, Kanagawa,
Japan: Department of Pharmacology, Kitasato University
School of Medicine; 2006. Available from: http://www.
researchgate.net/publication/7129235_A_Missing_Link_
Between_ a_High_Salt_Intake_and_Blood_Pressure_Increase
[accessed 23.04.15].
8. Victor RG, Kaplan NM. Systemic hypertension: mechanisms
and diagnosis. In: Libby P, Bonow RO, Mann DL, Zipes DP,
eds. In: Braunwald's Heart Disease: A Text Book of
Cardiovascular Medicine 8th ed. Philadelphia: Saunders;
2008:1028–1029 [chapter 40].
9. Philips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME,
Somers VK. Effects of obstructive sleep apnea on
endothelin-1 and blood pressure. J Hypertens. 1999;17:61–66.
10. Grundy SM. Metabolic syndrome: a multiplex cardiovascular
risk factor. J Clin Endocrinol Metab. 2007;92:399–404.
11. Padmanabhan TNC, Dani S, Chopra VK, Guha S, Vasnawala
H, Ammar R. Prevalence of sympathetic overactivity in
hypertensive patients – a pan India, non-interventional,
cross-sectional study. Indian Heart J. 2014;66:686–690.
12. Hart EC, Charkoudian N. Sympathetic neural mechanisms in
human blood pressure regulation. Curr Hypertens Rep.
2011;13:237–243.
13. Guyton AC, Hall JE. The autonomic nervous system and the
adrenal medulla. In: Text Book of Medical Physiology. 11th ed.
Delhi: Elsevier; 2006:754–757 [chapter 60].
14. Newton's laws of motion – Wikipedia, the free encyclopedia. 2015.
Available from: https://en.wikipedia.org/wiki/Newton%
27s_laws_of_motion [accessed 15.09.15].
15. Savage DD, Drayer JI, Henry WL, et al. Echocardiographic
assessment of cardiac anatomy and function in
hypertensive subjects. Circulation. 1979;59:623–632.
16. Cuspidi C, Ambrosioni E, Mancia G, et al. Role of
echocardiography and carotid ultrasonography in
stratifying risk in patients with essential hypertension: the
Assessment of Prognostic Risk Observational Survey. J
Hypertens. 2002;20:1307–1314.
17. Rasanen J, Debbs RH, Wood DC, Weiner S, Weil SR, Huhta JC.
Human fetal right ventricular ejection force under abnormal
loading conditions during the second half of pregnancy.
Ultrasound Obstet Gynecol. 1997;10:325–332.
18. Isaaz K, Ethevenot G, Admant P, Brembilla B, Pernot C. A
new Doppler method of assessing left ventricular ejection
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 6 8 5 – 6 9 2692force in chronic congestive heart failure. Am J Cardiol.
1989;64:81–87.
19. Shani BT, Boulu JJP, Cohen J. Sympathetic skin response a
method of assessment of unmyelinated axon dysfunction in
peripheral neuropathies. J Neurol Neurosurg Psychiatry.
1984;47:536–542.
20. Guinjoan SM, Bernabo JL, Cardinali DP. Cardiovascular tests
of autonomic function and sympathetic skin responses in
patients with major depression. J Neurol Neurosurg Psychiatry.
1995;59:299–302.
21. Saxena TK, Maheshwari S, Saxena M. Aetiopathogenesis of
type-2 diabetes mellitus: could chronic stress play an
important role? JAPI. 2014;62:484–489.
22. James PA, Oparil S, Carter BL, et al. 2014 evidence-based
guideline for the management of high blood pressure inadults: report from the panel members appointed to the
Eighth Joint National Committee (JNC 8). JAMA.
2014;311:507–520. http://dx.doi.org/10.1001/
jama.2013.284427.
23. Westfall TC, Westfall DP. Neurotransmission: the
autonomic and somatic motor nervous system. In: Goodman
& Gilman's. The Pharmacological Basis of Therapeutics. 12th ed.
New York: McGraw Hill; 2011:P171–P180 [chapter 8].
24. Guyton AC, Hall JE. Nervous regulation of the circulation,
rapid control of arterial pressure and Dominant role of the
kidney in long term regulation of arterial pressure and in
hypertension: the integrated system for pressure control. In:
Text Book of Medical Physiology. 11th ed. Delhi: Elsevier;
2006:210–221 [chapters 18 and 19].
